72
Participants
Start Date
July 26, 2022
Primary Completion Date
February 15, 2024
Study Completion Date
February 15, 2024
Crisaborole 2%
The adult caregiver will apply a thin layer of Crisaborole 2% topically on their child participant twice a day for 2 weeks.
Vehicle treatment
The adult caregiver will apply a thin layer of the vehicle treatment topically on their child participant twice a day for 2 weeks. The vehicle treatment is made of excipients of crisaborole ointment (non-medicated ointment).
Accelerometry device for children
Children participants will wear two wrist worn (or wrist worn AND ankle worn for 3 months up to \<2 years) accelerometry devices. Devices will be optional for child participants who have active AD on location of device placement, with a minimum of at least one wrist device needed for enrollment.
Accelerometry device for adult caregivers
Adult caregiver participants will wear two accelerometry devices (one on each wrist) and complete daily assessments related to scratching, sleeping habits, pain, AD severity, quality of life, and device comfort questionnaires.
BU CAMed Laboratory for Human Neurobiology, Boston
Collaborators (1)
Pfizer
INDUSTRY
Boston University
OTHER